Analysis of the effectiveness of complex pharmacotherapy using antibacterial agents and immunomodulators for bronchial pneumonia
Currently, for the treatment of acute respiratory diseases, some types of antibiotics are often prescribed in combination with various medications, including immunomodulators. However, in recent years, immunomodulators have increasingly been classified as medicines with unproven efficacy. This article studies various methods of treatment of bronchial pneumonia on the example of laboratory animals. In the first group of animals, the disease and recovery proceeds naturally, in the second – with the use of the antibiotic pefloxacin, in the third – with the use of complex treatment from the antibiotic pefloxacin and the immunomodulator erbisol. In this scientific study, the course of the disease was monitored, as well as the study of the main blood parameters. The study showed high efficacy of pefloxacin in the treatment of nonspecific bronchopneumonia (91.7%). At the same time, in the treatment of acute nonspecific bronchopneumonia with pefloxacin in combination with erbisol, recovery on the example of piglets came faster, and the disease itself proceeded more easily. The effectiveness of such a complex was 100%. It should be noted that the lack of comprehensive treatment not only delays the recovery process, but also leads to a fatal outcome.
How to cite this article:
Contact SPER Publications
SPER Publications and Solutions Pvt. Ltd.
HD - 236,
Near The Shri Ram Millenium School,
Noida-Greater Noida Expressway,
Noida-201301 [Delhi-NCR] India